364 related articles for article (PubMed ID: 33348472)
1. Dopamine D1 + D3 receptor density may correlate with parkinson disease clinical features.
Yang P; Knight WC; Li H; Guo Y; Perlmutter JS; Benzinger TLS; Morris JC; Xu J
Ann Clin Transl Neurol; 2021 Jan; 8(1):224-237. PubMed ID: 33348472
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?
Yang P; Perlmutter JS; Benzinger TLS; Morris JC; Xu J
Ageing Res Rev; 2020 Jan; 57():100994. PubMed ID: 31765822
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D3 Receptor in Parkinson Disease: A Prognosis Biomarker and an Intervention Target.
Xu J
Curr Top Behav Neurosci; 2023; 60():89-107. PubMed ID: 35711029
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal cross-sensitization of D1 and D3 receptors following pharmacological stimulation in the hemiparkinsonian rat.
Lanza K; Chemakin K; Lefkowitz S; Saito C; Chambers N; Bishop C
Psychopharmacology (Berl); 2020 Jan; 237(1):155-165. PubMed ID: 31435690
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D3 Receptor Modulates l-DOPA-Induced Dyskinesia by Targeting D1 Receptor-Mediated Striatal Signaling.
Solís O; Garcia-Montes JR; González-Granillo A; Xu M; Moratalla R
Cereb Cortex; 2017 Jan; 27(1):435-446. PubMed ID: 26483399
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of D2/D3 receptors increases efficacy of ropinirole in chronically 6-OHDA-lesioned Parkinsonian rats.
Matsukawa N; Maki M; Yasuhara T; Hara K; Yu G; Xu L; Kim KM; Morgan JC; Sethi KD; Borlongan CV
Brain Res; 2007 Jul; 1160():113-23. PubMed ID: 17573046
[TBL] [Abstract][Full Text] [Related]
7. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
[TBL] [Abstract][Full Text] [Related]
8. Selective overexpression of dopamine D3 receptors in the striatum disrupts motivation but not cognition.
Simpson EH; Winiger V; Biezonski DK; Haq I; Kandel ER; Kellendonk C
Biol Psychiatry; 2014 Nov; 76(10):823-31. PubMed ID: 24387821
[TBL] [Abstract][Full Text] [Related]
9. Coexpression of dopamine D1 and D3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions.
Ridray S; Griffon N; Mignon V; Souil E; Carboni S; Diaz J; Schwartz JC; Sokoloff P
Eur J Neurosci; 1998 May; 10(5):1676-86. PubMed ID: 9751140
[TBL] [Abstract][Full Text] [Related]
10. Biased G Protein-Independent Signaling of Dopamine D
Guitart X; Moreno E; Rea W; Sánchez-Soto M; Cai NS; Quiroz C; Kumar V; Bourque L; Cortés A; Canela EI; Bishop C; Newman AH; Casadó V; Ferré S
Mol Neurobiol; 2019 Oct; 56(10):6756-6769. PubMed ID: 30919214
[TBL] [Abstract][Full Text] [Related]
11. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum.
Aubert I; Ghorayeb I; Normand E; Bloch B
J Comp Neurol; 2000 Feb; 418(1):22-32. PubMed ID: 10701753
[TBL] [Abstract][Full Text] [Related]
12. Opposing relationships of BMI with BOLD and dopamine D2/3 receptor binding potential in the dorsal striatum.
Cosgrove KP; Veldhuizen MG; Sandiego CM; Morris ED; Small DM
Synapse; 2015 Apr; 69(4):195-202. PubMed ID: 25664726
[TBL] [Abstract][Full Text] [Related]
13. Implication of dopamine D3 receptor activation in the reversion of Parkinson's disease-related motivational deficits.
Carnicella S; Drui G; Boulet S; Carcenac C; Favier M; Duran T; Savasta M
Transl Psychiatry; 2014 Jun; 4(6):e401. PubMed ID: 24937095
[TBL] [Abstract][Full Text] [Related]
14. The D3 dopamine receptor: From structural interactions to function.
Fiorentini C; Savoia P; Bono F; Tallarico P; Missale C
Eur Neuropsychopharmacol; 2015 Sep; 25(9):1462-9. PubMed ID: 25532864
[TBL] [Abstract][Full Text] [Related]
15. Regional and source-based patterns of [
Worhunsky PD; Matuskey D; Gallezot JD; Gaiser EC; Nabulsi N; Angarita GA; Calhoun VD; Malison RT; Potenza MN; Carson RE
Neuroimage; 2017 Mar; 148():343-351. PubMed ID: 28110088
[TBL] [Abstract][Full Text] [Related]
16. Neuroadaptations to hyperdopaminergia in dopamine D3 receptor-deficient mice.
Le Foll B; Diaz J; Sokoloff P
Life Sci; 2005 Jan; 76(11):1281-96. PubMed ID: 15642598
[TBL] [Abstract][Full Text] [Related]
17. Genetic suppression of the dopamine D3 receptor in striatal D1 cells reduces the development of L-DOPA-induced dyskinesia.
Lanza K; Centner A; Coyle M; Del Priore I; Manfredsson FP; Bishop C
Exp Neurol; 2021 Feb; 336():113534. PubMed ID: 33249031
[TBL] [Abstract][Full Text] [Related]
18. Dimerization of dopamine D1 and D3 receptors in the regulation of striatal function.
Fiorentini C; Busi C; Spano P; Missale C
Curr Opin Pharmacol; 2010 Feb; 10(1):87-92. PubMed ID: 19837631
[TBL] [Abstract][Full Text] [Related]
19. Reduced striatal dopamine D1-D2 receptor heteromer expression and behavioural subsensitivity in juvenile rats.
Perreault ML; Hasbi A; Alijaniaram M; O'Dowd BF; George SR
Neuroscience; 2012 Dec; 225():130-9. PubMed ID: 22986162
[TBL] [Abstract][Full Text] [Related]
20. Presynaptic control of [
Briones-Lizardi LJ; Cortés H; Avalos-Fuentes JA; Paz-Bermúdez FJ; Aceves J; Erlij D; Florán B
Neuroscience; 2019 May; 406():563-579. PubMed ID: 30930129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
